The name of the city of Leeds is derived from the old Brythonic word Ladenses meaning “people of the fast-flowing river”, in reference to the River Aire which still flows through the city.

The ADAMAS team at the RQA consists of Jerry Young, Business Development Manager, who will be on hand to discuss any auditing needs you may have, and to introduce you to other members of our team. Ian Brady, Global Head of Pharmacovigilance, who heads a team of very experienced Consultants including ex-MHRA GVP inspectors; Christine Henderson, Quality and Training Director; and Gael Love, one of our experienced Consultants. All are looking forward to meeting you.

What sets ADAMAS apart is the team of 25 full-time, experienced auditors, that includes former MHRA (GVP & GCP) inspectors, and offices in three global regions, USA, EMEA and APAC, to support your international needs. This allows ADAMAS to deliver high quality and consistent project deliverables throughout the world.

This year, ADAMAS will present a poster entitled “Conducting remote vendor audits”, and our team would be interested in your thoughts and your own experience.

For a bit of fun, please enter our raffle to win a Kindle PaperWhite. Visit our stand and ask our team members for details.

If you’re not able to get to the RQA Conference, but would like to learn more about ADAMAS, please give us a call on +44 (0) 1344 751 210 or contact Jerry Young at jerry.young@adamasconsulting.com

See you in Leeds.

The ADAMAS Corporate Brochure 2016

 

Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

×
Regulatory Environment

 

The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.

adamas-quality-assurance-services

 

ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.

 

×
How to be a Clinical Auditor

 

‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

×
Benchmarking Data

 

Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

×
Is your QMS compliant?

 

Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

×
ICH (E6) R2 Addendum - Step 4

 

Please enter your details to complete the download.

×

×